Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ANDEXANET ALFA Cause Pulmonary embolism? 38 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Pulmonary embolism have been filed in association with ANDEXANET ALFA (ANDEXXA). This represents 3.5% of all adverse event reports for ANDEXANET ALFA.

38
Reports of Pulmonary embolism with ANDEXANET ALFA
3.5%
of all ANDEXANET ALFA reports
21
Deaths
10
Hospitalizations

How Dangerous Is Pulmonary embolism From ANDEXANET ALFA?

Of the 38 reports, 21 (55.3%) resulted in death, 10 (26.3%) required hospitalization, and 18 (47.4%) were considered life-threatening.

Is Pulmonary embolism Listed in the Official Label?

Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for ANDEXANET ALFA.

What Other Side Effects Does ANDEXANET ALFA Cause?

Death (175) Cerebral infarction (139) Off label use (64) Cerebral haemorrhage (50) Thrombosis (43) Acute myocardial infarction (42) Myocardial infarction (42) Cerebrovascular accident (40) Ischaemic stroke (38) Heparin resistance (37)

What Other Drugs Cause Pulmonary embolism?

RIVAROXABAN (3,282) LENALIDOMIDE (2,976) APIXABAN (2,714) ETHINYL ESTRADIOL\ETONOGESTREL (2,370) TESTOSTERONE (2,043) RITUXIMAB (1,764) ADALIMUMAB (1,663) PREDNISONE (1,586) METHOTREXATE (1,508) DEXAMETHASONE (1,336)

Which ANDEXANET ALFA Alternatives Have Lower Pulmonary embolism Risk?

ANDEXANET ALFA vs ANDROGEL ANDEXANET ALFA vs ANETHOLTRITHION ANDEXANET ALFA vs ANGIOTENSIN II ANDEXANET ALFA vs ANHYDROUS CITRIC ACID\ASPIRIN\SODIUM BICARBONATE ANDEXANET ALFA vs ANHYDROUS CITRIC ACID\MAGNESIUM\SODIUM PICOSULFATE

Related Pages

ANDEXANET ALFA Full Profile All Pulmonary embolism Reports All Drugs Causing Pulmonary embolism ANDEXANET ALFA Demographics